HER2-mTOR signaling–driven breast cancer cells require ER-associated degradation to survive
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HER2-mTOR signaling–driven breast cancer cells require ER-associated degradation to survive
Authors
Keywords
-
Journal
Science Signaling
Volume 8, Issue 378, Pages ra52-ra52
Publisher
American Association for the Advancement of Science (AAAS)
Online
2015-05-27
DOI
10.1126/scisignal.aaa6922
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality
- (2014) Livnat Jerby-Arnon et al. CELL
- Mitogen-activated protein kinase (MAPK) phosphatase-3 (MKP-3) displays a p-JNK-MAPK substrate preference in astrocytes in vitro
- (2014) Christian Ndong et al. NEUROSCIENCE LETTERS
- ER stress-induced cell death mechanisms
- (2013) Renata Sano et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Epidermal growth factor receptor targeting in cancer: A review of trends and strategies
- (2013) Chetan Yewale et al. BIOMATERIALS
- Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress
- (2013) R. M. Young et al. GENES & DEVELOPMENT
- Inconsistency in large pharmacogenomic studies
- (2013) Benjamin Haibe-Kains et al. NATURE
- Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
- (2013) Paola Magnaghi et al. Nature Chemical Biology
- Targeting the unfolded protein response in disease
- (2013) Claudio Hetz et al. NATURE REVIEWS DRUG DISCOVERY
- A comparative survey of functional footprints of EGFR pathway mutations in human cancers
- (2013) A Lane et al. ONCOGENE
- NetWalker: a contextual network analysis tool for functional genomics
- (2012) Kakajan Komurov et al. BMC GENOMICS
- Control of Tumor Bioenergetics and Survival Stress Signaling by Mitochondrial HSP90s
- (2012) Young Chan Chae et al. CANCER CELL
- TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
- (2012) Anurag Singh et al. CELL
- The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
- (2012) Madhu S. Kumar et al. CELL
- Cleaning Up: ER-Associated Degradation to the Rescue
- (2012) Jeffrey L. Brodsky CELL
- Cancer Vulnerabilities Unveiled by Genomic Loss
- (2012) Deepak Nijhawan et al. CELL
- β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
- (2012) Joseph Rosenbluh et al. CELL
- ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth
- (2012) Lori S. Hart et al. JOURNAL OF CLINICAL INVESTIGATION
- The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells
- (2012) Kakajan Komurov et al. Molecular Systems Biology
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- Passenger deletions generate therapeutic vulnerabilities in cancer
- (2012) Florian L. Muller et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- The unfolded protein response: controlling cell fate decisions under ER stress and beyond
- (2012) Claudio Hetz NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies
- (2012) B Luo et al. ONCOGENE
- Improving Treatment of HER2-Positive Cancers: Opportunities and Challenges
- (2012) H. M. Stern Science Translational Medicine
- Resisting Targeted Therapy: Fifty Ways to Leave Your EGFR
- (2011) Paul Workman et al. CANCER CELL
- Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
- (2011) Thomas De Raedt et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Quantitative Cell-based Protein Degradation Assays to Identify and Classify Drugs That Target the Ubiquitin-Proteasome System
- (2011) Tsui-Fen Chou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer therapy based on oncogene addiction
- (2011) Frank McCormick JOURNAL OF SURGICAL ONCOLOGY
- Defining human ERAD networks through an integrative mapping strategy
- (2011) John C. Christianson et al. NATURE CELL BIOLOGY
- Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways
- (2011) T.-F. Chou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
- (2011) H. W. Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The dual-specificity MAP kinase phosphatases: critical roles in development and cancer
- (2010) O. Bermudez et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments
- (2010) James H Bullard et al. BMC BIOINFORMATICS
- The CrebA/Creb3-like transcription factors are major and direct regulators of secretory capacity
- (2010) Rebecca M. Fox et al. JOURNAL OF CELL BIOLOGY
- International network of cancer genome projects
- (2010) Thomas J. Hudson (Chairperson) et al. NATURE
- The ERAD Inhibitor Eeyarestatin I Is a Bifunctional Compound with a Membrane-Binding Domain and a p97/VCP Inhibitory Group
- (2010) Qiuyan Wang et al. PLoS One
- Use of Data-Biased Random Walks on Graphs for the Retrieval of Context-Specific Networks from Genomic Data
- (2010) Kakajan Komurov et al. PLoS Computational Biology
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells
- (2009) T. W. Miller et al. CLINICAL CANCER RESEARCH
- Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages
- (2009) Gabriela Molina et al. Nature Chemical Biology
- HMG-CoA reductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression
- (2008) Jui-Ching Chen et al. CARDIOVASCULAR RESEARCH
- Inhibition of p97-dependent Protein Degradation by Eeyarestatin I
- (2008) Qiuyan Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation